[Arterial hypertension in cancer patients treated with antiangiogenic agents]

R Roa-Chamorro; L Torres-Quintero; P González-Bustos

doi:10.1016/j.hipert.2021.02.003

[Arterial hypertension in cancer patients treated with antiangiogenic agents]

Hipertens Riesgo Vasc. 2021 Jul-Sep;38(3):151-155. doi: 10.1016/j.hipert.2021.02.003. Epub 2021 Mar 9.

[Article in Spanish]

Authors

R Roa-Chamorro¹, L Torres-Quintero², P González-Bustos²

Affiliations

¹ Hospital Universitario Virgen de las Nieves, Granada, España. Electronic address: ricardoroa@gmail.com.
² Hospital Universitario Virgen de las Nieves, Granada, España.

PMID: 33706996
DOI: 10.1016/j.hipert.2021.02.003

Abstract

Survival of neoplasms has improved significantly in recent years. An increase in the incidence of cardiovascular disease has been observed. This is due to increasing age of patients and the side effects of chemotherapy. Anti-angiogenic drugs frequently cause hypertension. This may force the reduction or suspension of chemotherapy treatment. We present the cases of three patients treated with different anti-angiogenic drugs. All three developed secondary arterial hypertension.

Keywords: Anti-angiogenic therapy; Arterial hypertension; Cancer; Cáncer; Hipertensión arterial; Terapia anti-angiogénica.

Publication types

Case Reports

MeSH terms

Angiogenesis Inhibitors* / adverse effects
Cardiovascular Diseases*
Humans
Hypertension* / chemically induced
Hypertension* / drug therapy
Neoplasms* / complications
Neoplasms* / drug therapy

Substances

Angiogenesis Inhibitors